Marcaine

Bupivacaine hydrochloride, the active ingredient in Marcaine, is a local anesthetic (amide type) presented as a sterile injectable solution for infiltration use. It provides prolonged numbness for surgical, dental, obstetric and postoperative pain procedures in adult patients and is commonly employed by anesthesiologists and surgeons.

GNH USA supplies Marcaine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across EU and global markets. We partner with accredited logistics providers to maintain product integrity during transit.

Marcaine, a long‑acting amide local anesthetic, is used to achieve regional nerve blockade for several procedural categories.

- Surgical procedures: provides reliable local anesthesia to facilitate operative interventions and reduce intra‑operative pain. - Dental procedures: enables profound numbness of oral tissues for extractions, restorations and periodontal surgery. - Obstetric and gynecologic procedures: offers analgesia for labor, cesarean sections and gynecologic surgeries. - Post‑operative pain management: extends analgesic effect to control pain during the immediate recovery period.

Marcaine may be associated with a range of adverse reactions, varying from mild and transient to severe and potentially life‑threatening.

Common Side Effects: - Injection site pain or burning - Transient numbness or tingling - Mild hypotension - Metallic taste

Serious or Rare Side Effects: - Cardiac arrhythmias or cardiac arrest - Severe hypotension or cardiovascular collapse - Central nervous system toxicity such as seizures

When using Marcaine, clinicians should observe several precautionary measures to minimize risk. - Pregnancy: safety category unknown; avoid unless benefit outweighs potential risk. - Elderly patients: monitor cardiovascular status due to increased susceptibility to hypotension. - Cardiac disease: use cautiously as bupivacaine may precipitate arrhythmias. - Concurrent use of other local anesthetics: avoid additive toxicity. - Allergy: discontinue immediately if signs of hypersensitivity appear. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Marcaine can interact with other medicines, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): increase risk of cardiotoxicity. - Beta‑blockers (e.g., propranolol): may exacerbate bradycardia and hypotension. - General anesthetics such as halothane or sevoflurane: potentiate central nervous system depression. - Other local anesthetics: additive neuro‑ and cardiotoxic effects.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: may increase bleeding tendency. - Opioids: can enhance sedation and respiratory depression. - Diuretics: may affect plasma protein binding and increase free drug levels.